09.01.17
Johnson & Johnson’s (J&J) corporate sales rose 1.95% to $18.8 billion for the second quarter of 2017. According to the company, domestic OTC and Neutrogena beauty products helped offset poor performance in baby care for the quarter.
Worldwide consumer division sales increased 1.7% to $3.5 billion. Domestic sales rose 7.4% while international sales fell 2.2%, according to the company.
Worldwide consumer division sales increased 1.7% to $3.5 billion. Domestic sales rose 7.4% while international sales fell 2.2%, according to the company.